Abstract
Purpose
The aim of this study was to analyse the safety profile and efficacy of ab interno viscocanaloplasty (ABiC) through to 12 months post-operatively.
Methods
In this retrospective study, the medical records of all patients who underwent ABiC between September 2015 and December 2019 were analysed. Complete success was defined as a 12-month reduction in intraocular pressure (IOP) ≥ 20% from baseline with no concomitant medications. Qualified success criteria were identical, with no more medications than at baseline.
Results
In all, 54 eyes of 41 patients were analysed. Mean IOP decreased from 23.6 ± 7.4 mmHg preoperatively to 14.2 ± 2.9 mmHg (-39.8%; p < 0.001) after 12 months. Concomitantly, the number of anti-glaucoma treatment dropped from 2.9 ± 1.0 to 0.6 ± 1.1 (-79.3%; p < 0.001). Amongst patients with a baseline MD < -12.0 dBs, mean IOP decreased from 22.8 ± 9.8 mmHg to 13.8 ± 4.4 mmHg (p = 0.049), with a concomitant reduction of medications from 2.8 ± 1.3 to 1.2 ± 1.3 (p < 0.001). Complete success at 12 months was achieved in 46% of eyes, and qualified success was achieved in 65% of eyes. Amongst eyes with a baseline MD < -12.0 dBs, 50% achieved complete success, and 83.3% achieved qualified success. A total of 19 eyes (35.2%) were considered surgical failure, all due to uncontrolled IOP. Of them, 7 eyes (13.0%) required further filtering surgery. Twelve post-operative adverse events were observed, with early post-operative IOP spikes being the most common (22.2%).
Conclusions
ABIC achieved a statistically significant reduction in IOP and anti-glaucoma medications through 12 months, while maintaining a favourable safety profile in mild-to-severe open-angle glaucoma.
Similar content being viewed by others
Data availability
Data are available from the corresponding author upon reasonable request.
References
Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262–267
Inoue K (2014) Managing adverse effects of glaucoma medications. Clin Ophthalmol 8:903–913
Zhang X, Vadoothker S, Munir WM, Saeedi O (2019) Ocular surface disease and glaucoma medications: a clinical approach. Eye Contact Lens. 45(1):11–18
Erdem E, Williams A, Kuchar SD, Waisbourd M, Spaeth GL (2015) Long-term (>8 years) evaluation of progression in patients with low-pressure glaucoma. Eur J Ophthalmol 25(6):490–495
Thakur S, Ichhpujani P, Kumar S. Grafts in Glaucoma Surgery: A Review of the Literature. Asia Pac J Ophthalmol (Phila). 2017 Sep-Oct;6(5):469–476.
Gedde SJ, Herndon LW, Brandt JD et al (2012) Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol 153(5):804-814.e1
Vastardis I, Kontopoulou K, Fili S, Gatzioufas Z, Kohlhaas M (2020) Comparison of performance between two microcatheter systems in ab externo canaloplasty: a retrospective comparison study. Eur J Ophthalmol 30(3):487–493
Grieshaber MC, Pienaar A, Olivier J, Stegmann R (2010) Comparing two tensioning suture sizes for 360 degrees viscocanalostomy (canaloplasty): a randomised controlled trial. Eye (Lond) 24(7):1220–1226
Heuer DK, Barton K, Grehn F et al (2008) Conditions on definitions of success. In: Shaarawy TM, Sherwood MB, Grehn F (eds) Guidelines on design and reporting of glaucoma surgical trials. Kugler Publications, Amsterdam, pp 15–24
Khoshnood B, Mesbah M, Jeanbat V et al (2010) Transforming scales of measurement of visual acuity at the group level. Ophthal Physiol Opt 30:816–823
Baykara M, Poroy C, Erseven C (2019) Surgical outcomes of combined gonioscopy-assisted transluminal trabeculotomy and cataract surgery. Indian J Ophthalmol 67(4):505–508
Davids AM, Pahlitzsch M, Boeker A, Winterhalter S, Maier-Wenzel AK, Klamann M (2019) Ab interno canaloplasty (ABiC)-12-month results of a new minimally invasive glaucoma surgery (MIGS). Graefes Arch Clin Exp Ophthalmol 257(9):1947–1953
Körber N (2017) Kanaloplastik ab interno – eine minimalinvasive Alternative [Canaloplasty ab interno–a Minimally Invasive Alternative]. Klin Monbl Augenheilkd 234(8):991–995
Vastardis I, Fili S, Perdikakis G, Gatzioufas Z, Kohlhaas M (2020) Estimation of risk-benefit ratio and comparison of post-operative efficacy results between trabeculectomy and canaloplasty. Eur J Ophthalmol 13:1120672120914491
Godfrey DG, Fellman RL, Neelakantan A (2009) Canal surgery in adult glaucomas. Curr Opin Ophthalmol 20(2):116–121
Lewis RA, von Wolff K, Tetz M et al (2011) Canaloplasty: three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma. J Cataract Refract Surg 37(4):682–690
Gillmann K, Mansouri K (2020) Minimally invasive glaucoma surgery: where is the evidence? Asia Pac J Ophthalmol (Phila) 9(3):203–214
Mansouri K, Shaarawy T (2015) Update on Schlemm’s canal based procedures. Middle East Afr J Ophthalmol 22(1):38–44
Riva I, Brusini P, Oddone F, Michelessi M, Weinreb RN, Quaranta L (2019) Canaloplasty in the treatment of open-angle glaucoma: a review of patient selection and outcomes. Adv Ther 36(1):31–43. https://doi.org/10.1007/s12325-018-0842-6
Arimura S, Miyake S, Iwasaki K et al (2018) Randomised clinical trial for postoperative complications after Ex-PRESS implantation versus Trabeculectomy with 2-Year Follow-Up. Sci Rep 8(1):16168
Al Habash A, Alrushoud M, Al Abdulsalam O, Al Somali AI, Aljindan M, Al Ahmadi AS (2020) Combined gonioscopy-assisted transluminal trabeculotomy (GATT) with Ab interno canaloplasty (ABiC) in conjunction with phacoemulsification: 12-month outcomes. Clin Ophthalmol 25(14):2491–2496
Cagini C, Peruzzi C, Fiore T, Spadea L, Lippera M, Lippera S. Canaloplasty: current value in the management of glaucoma. J Ophthalmol 2016:7080475
Nguyen AH, Fatehi N, Romero P et al (2018) Observational outcomes of initial trabeculectomy with mitomycin c in patients of African descent vs patients of European descent: five-year results. JAMA Ophthalmol 136:1106–1113
Funding
No external funding was received for this work.
Author information
Authors and Affiliations
Contributions
Gillmann K has contributed to design, analysis, graphics, writing and supervision, Aref A and Niegowski LJ collected the data, and Baumgartner JM was involved in design, surgery, treating ophthalmologist, analysis and review.
Corresponding author
Ethics declarations
Conflicts of interest
None of the co-authors have any relationship with any of the companies or products discussed in this study and therefore have no conflict of interest to declare.
Ethics approval
This retrospective study was ethically validated.
Consent to participate
Informed consent was obtained from all participants.
Consent for publication
Consent for publication was obtained from all participants as part of the informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gillmann, K., Aref, A., Niegowski, L.J. et al. Combined Ab interno viscocanaloplasty (ABiC) in open-angle glaucoma: 12-month outcomes. Int Ophthalmol 41, 3295–3301 (2021). https://doi.org/10.1007/s10792-021-01891-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-021-01891-1